'Global Radiopharmaceutical Market Worth Over $5 Billion in 2017' Says Visiongain Report
August 16, 2018
August 16, 2018
LONDON, England, Aug. 16 -- Visiongain, a independent media company, issued the following news release:
Visiongain's new report The Global Radiopharmaceutical Market Forecast 2017-2027 (https://www.visiongain.com/report/the-global-radiopharmaceutical-market-forecast-2017-2027/): Revenue Prospects by Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others) Radioisotope (Tc-99, F-18, I-131, Lu-177, Y-90, Ga-68, Ga-67, Rb-82, I-123, I-125, . . .
Visiongain's new report The Global Radiopharmaceutical Market Forecast 2017-2027 (https://www.visiongain.com/report/the-global-radiopharmaceutical-market-forecast-2017-2027/): Revenue Prospects by Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others) Radioisotope (Tc-99, F-18, I-131, Lu-177, Y-90, Ga-68, Ga-67, Rb-82, I-123, I-125, . . .